MOMC-5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma

BACKGROUND: Medulloblastoma (MB) is the most common malignant paediatric brain tumour and a leading cause of cancer-related mortality and morbidity. Existing treatment protocols are aggressive in nature resulting in significant neurological, intellectual and physical disabilities for the children un...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurooncol Adv
Hauptverfasser: Genovesi, Laura, Millar, Amanda, Tolson, Elissa, Singleton, Matthew, Hassall, Emily, Kojic, Marija, Brighi, Caterina, Girald, Emily, Andradas, Clara, Kuchibhotla, Mani, Endersby, Raelene, Gottardo, Nicholas, Bernard, Anne, Adolphe, Christelle, Olson, James, Davis, Melissa, Wainwright, Brandon
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2021
Schlagworte:
Supplement Abstracts
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255431/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab070.015
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge